Neurologic Imaging

Which Imaging Is Best for Staging Suspected Major Salivary Gland Cancer?

·
Which Imaging Is Best for Staging Suspected Major Salivary Gland Cancer?

A 68-year-old patient presents to your clinic with a firm, painless mass in the right preauricular region that has slowly enlarged over the past three months. On examination, you palpate a 3 cm nodule within the substance of the parotid gland. There is no facial nerve weakness. Fine-needle aspiration (FNA) is suspicious for a malignant process, possibly mucoepidermoid carcinoma. You now face the critical decision of initial staging: which imaging study will best delineate the primary tumor, assess for perineural invasion, and evaluate for regional nodal metastases? This is the essential first step in determining resectability and guiding therapy. For this specific clinical scenario—initial staging of a suspected major salivary gland cancer—the American College of Radiology (ACR) Appropriateness Criteria rates MRI orbits face neck without and with IV contrast as Usually appropriate.

Who Fits This Clinical Scenario?

This guidance applies to adult patients presenting with a new diagnosis or strong clinical suspicion of malignancy in one of the major salivary glands: the parotid, submandibular, or sublingual glands. The key indication is the need for initial staging before treatment. This includes defining the local extent of the primary tumor (T stage), assessing for regional lymph node involvement (N stage), and evaluating for features that significantly alter management, such as perineural spread or invasion of adjacent structures.

This workflow is distinct from other head and neck cancer scenarios. It is crucial not to apply this guidance to patients with:

  • Suspected cancer of the oral cavity or oropharynx: These tumors have different patterns of spread and often require different imaging protocols focused on the mucosal surfaces and deep spaces of the pharynx.
  • Suspected nasopharyngeal carcinoma: This entity has a strong association with Epstein-Barr virus (EBV) and a high propensity for skull base invasion and specific nodal spread patterns (e.g., retropharyngeal nodes), necessitating a dedicated imaging approach.
  • Post-treatment surveillance: Imaging after surgery, radiation, or chemotherapy follows a different set of guidelines focused on detecting recurrence, which may have a different appearance than a primary tumor.

This article is exclusively for the initial workup of a primary major salivary gland mass where cancer is the leading concern.

What Diagnoses Are You Working Up in This Scenario?

While a salivary gland mass can represent a wide range of pathologies, the imaging workup for suspected malignancy is focused on identifying features that differentiate cancer from benign entities and define its extent. The differential diagnosis you are evaluating includes:

Malignant Salivary Gland Tumors: This is the primary concern. The most common malignant tumor of the parotid gland is mucoepidermoid carcinoma, followed by adenoid cystic carcinoma (ACC) and acinic cell carcinoma. ACC is infamous for its propensity for perineural invasion, a critical finding that imaging must be optimized to detect. Imaging helps characterize the tumor’s margins (infiltrative vs. well-defined), its relationship to the facial nerve, and invasion into adjacent muscle, bone, or skin.

Benign Salivary Gland Tumors: The most common salivary gland tumors are benign, with pleomorphic adenoma being the most frequent overall. While often appearing as well-circumscribed, encapsulated masses, they can sometimes have ambiguous features. Imaging helps distinguish these from low-grade malignancies and assesses for signs of malignant transformation, though definitive diagnosis often requires tissue sampling.

Metastatic Disease to Salivary Glands or Nodes: The parotid gland and its intra-glandular lymph nodes are common sites for metastases, particularly from cutaneous squamous cell carcinoma or melanoma of the head and neck. Imaging is essential for identifying these secondary lesions and searching for an unknown primary source if one is not already identified.

Lymphoma: Primary lymphoma of the salivary gland can occur, often in the context of Sjögren’s syndrome. It typically presents as diffuse glandular enlargement or multiple masses. Imaging helps assess the extent of glandular involvement and evaluate for systemic disease by identifying other involved nodal stations.

Why Is MRI of the Orbits, Face, and Neck the Recommended Study?

For the initial staging of a suspected major salivary gland malignancy, the ACR designates MRI orbits face neck without and with IV contrast as Usually appropriate. This recommendation is based on MRI’s superior soft tissue contrast resolution, which is critical for answering the key clinical questions in this scenario.

The primary advantage of MRI is its unparalleled ability to detect perineural spread, particularly along the facial nerve (CN VII) and trigeminal nerve (CN V). This is a common and prognostically significant feature of malignancies like adenoid cystic carcinoma. Contrast-enhanced, fat-suppressed T1-weighted sequences can highlight nerve enhancement and thickening, which directly impacts surgical planning and the need for adjuvant radiation. MRI also excels at delineating the tumor’s relationship to the deep lobe of the parotid, the parapharyngeal space, and the skull base.

While other modalities are considered, they have specific limitations for this initial staging question:

  • CT neck with IV contrast is also rated Usually appropriate and is a valid alternative, especially if MRI is contraindicated or unavailable. CT is superior for detecting cortical bone invasion and is faster to acquire. However, its soft tissue resolution is inferior to MRI, making it less sensitive for subtle perineural invasion. CT involves ionizing radiation (☢☢☢ 1-10 mSv).
  • US neck is rated May be appropriate. Ultrasound is an excellent tool for initial characterization of a palpable mass and for guiding fine-needle aspiration. However, it is operator-dependent and cannot fully assess the deep lobe of the parotid, the skull base, or the full extent of regional nodal disease, making it insufficient for comprehensive staging.
  • FDG-PET/CT skull base to mid-thigh is rated Usually appropriate, but it serves a different purpose. It is not typically the first-line modality for local T-staging but is highly valuable for detecting distant metastases (M-staging) and identifying occult nodal disease, especially in high-grade or advanced-stage cancers. It carries the highest radiation dose (☢☢☢☢ 10-30 mSv).

The choice of MRI as the primary modality prioritizes the detailed local and regional anatomical information needed to plan definitive treatment. It provides this information without any ionizing radiation (O 0 mSv).

What’s Next After MRI? Downstream Workflow

The results of the staging MRI will guide the subsequent steps in the patient’s management, typically determined in a multidisciplinary tumor board. The workflow branches based on the findings:

  • If the MRI shows a resectable tumor without distant spread: The patient will likely proceed to surgical resection (e.g., parotidectomy with facial nerve preservation, if possible) and neck dissection if there is evidence of nodal disease. The detailed MRI anatomy of the tumor’s relationship to the facial nerve is paramount for surgical planning.
  • If the MRI shows extensive local invasion or perineural spread to the skull base: This may render the tumor unresectable or require a more extensive surgical approach. The patient may be considered for neoadjuvant therapy or definitive chemoradiation. The MRI findings are critical for radiation oncology planning to ensure adequate coverage of the tumor and paths of neural spread.
  • If the MRI is suspicious for nodal disease or the primary tumor is high-grade: The next step is often to complete staging for distant metastases. This typically involves ordering an FDG-PET/CT skull base to mid-thigh, which is rated Usually appropriate for this purpose. A CT of the chest may also be considered.
  • If the MRI is indeterminate or suggests a benign process: If the findings are equivocal and FNA was inconclusive, an open biopsy or excisional biopsy may be necessary for a definitive diagnosis. If findings are classic for a benign entity like a pleomorphic adenoma, the patient may proceed to elective surgical excision without the need for further staging.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup of a salivary gland mass requires attention to detail to avoid common errors that can delay diagnosis or lead to incomplete staging.

  • Ordering an incomplete MRI protocol: A standard “MRI neck” may not include the dedicated thin-section, high-resolution sequences through the facial nerve and skull base that are essential for detecting perineural spread. Be explicit when ordering: “MRI orbits/face/neck without and with contrast for evaluation of parotid mass, with attention to the facial nerve.”
  • Relying solely on ultrasound for staging: While excellent for initial detection and biopsy guidance, ultrasound cannot provide the comprehensive T- and N-stage information required for treatment planning.
  • Misinterpreting facial nerve enhancement: Post-inflammatory changes (e.g., Bell’s palsy) can also cause nerve enhancement. Clinical correlation is essential to distinguish this from tumor-related perineural spread.
  • Forgetting the skin: Always perform a thorough skin examination of the head and neck, as cutaneous malignancies are a common source of metastases to the parotid lymph nodes.

If the imaging reveals extensive disease, skull base involvement, or features suggesting a rare histology, escalation to a multidisciplinary head and neck cancer tumor board is the standard of care.

Related ACR Topics and Tools

For a comprehensive overview of imaging for all head and neck cancer presentations, this depth piece is best used alongside its parent topic article. The following resources provide additional context for evidence-based imaging decisions.

Frequently Asked Questions

Why is MRI preferred over CT for a parotid mass when both are ‘Usually Appropriate’?

MRI is generally preferred because its superior soft tissue contrast provides a much clearer view of the tumor’s relationship to the facial nerve and is more sensitive for detecting perineural spread, a critical factor in staging and treatment planning for many salivary gland cancers like adenoid cystic carcinoma. CT is a strong alternative if MRI is contraindicated or unavailable, and it is better for assessing bone invasion.

Should I order an MRI of the head or an MRI of the neck?

Neither. The correct ACR-recommended study is a dedicated ‘MRI orbits face neck without and with IV contrast.’ This protocol is specifically designed to cover the entire course of the relevant cranial nerves (like V and VII) from the brainstem through the skull base and into the soft tissues of the face and neck, which is not achieved with a standard brain or neck protocol alone.

When is a PET/CT scan necessary for a salivary gland tumor?

An FDG-PET/CT is rated ‘Usually appropriate’ and is most valuable for completing the staging process once a high-grade malignancy is confirmed or suspected. Its primary roles are to detect regional nodal metastases that may not be obvious on MRI/CT and to screen for distant metastases (e.g., in the lungs, liver, or bones), which would significantly change the treatment approach.

Is a biopsy always needed before ordering staging imaging?

Not always, but it is highly recommended. A fine-needle aspiration (FNA) can often provide a histologic diagnosis (e.g., mucoepidermoid carcinoma vs. pleomorphic adenoma), which helps interpret the imaging findings in the correct clinical context. However, if a mass is highly suspicious for malignancy based on clinical exam and initial ultrasound, it is reasonable to proceed with staging MRI while awaiting biopsy results to avoid delays.

What if the mass is in the submandibular or sublingual gland instead of the parotid?

The same imaging principles and recommendations apply. An ‘MRI orbits face neck without and with IV contrast’ remains the ‘Usually appropriate’ study for initial staging. The key anatomical relationships will differ—for example, involvement of the lingual nerve, hypoglossal nerve, and floor of the mouth are key concerns for submandibular and sublingual gland cancers—but MRI remains the superior modality for assessing these soft tissue structures.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026